Atlas Trials

Effect of Yangxinshi Tablet on Exercise Tolerance in Patients With Chronic Coronary Syndrome(MET STUDY)

Clinical trial NCT05978089 · UNKNOWN

Trial details

NCT number
NCT05978089
Sponsor
Dongzhimen Hospital, Beijing
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Coronary Syndrome
Start date
2023-11-08
Primary completion
2025-06-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.